BioSpace News Archive

“I wanted to create a safe and simple way to wash, scratch and massage my back after my neck and shoulder surgery,” said an inventor, from Applegate, Mich., “so I invented the BACK SCRATCHER MASSAGER.”

Boehringer Ingelheim today announced that the SENSCIS® trial met its primary endpoint: reduction in the annual rate of decline in forced vital capacity (FVC) in patients with systemic sclerosis associated interstitial lung disease (SSc-ILD)

Oncopeptides AB (Nasdaq Stockholm: ONCO) announced today that, after discussions with the FDA, the company has initiated the preparation for submitting a New Drug Application (NDA) for accelerated approval of melflufen for the treatment of patients with triple-class refractory multiple myeloma.

Individuals and Organizations Honored for Positive Global Impact of Radiology Services at American College of Radiology Annual Meeting

Joins 18 states, including California, New York, and Florida in banning the sale of OTC cough medicine to minors

Donaldson Company, Inc. (NYSE: DCI), a leading worldwide manufacturer of innovative filtration products and solutions, today broke ground on a $15 million Material Research Center at its corporate headquarters in Bloomington, Minnesota.

The Biotechnology Innovation Organization (BIO) today announced that former U.S. Department of Agriculture (USDA) Secretary and former two-term Governor of Iowa Tom Vilsack will receive the 12th annual George Washington Carver Award for Innovation in Industrial Biotechnology

Galt Medical, a subsidiary of Theragenics Corporation® and a global supplier of access and procedure products for a range of interventional and endovascular procedures, today announced it has acquired Arrotek Medical Limited

UCB announced that the U.S. Food and Drug Administration has approved a New Drug Application for the company’s newest anti-epileptic drug NAYZILAM® nasal spray CIV, a benzodiazepine indicated for the acute treatment of intermittent, stereotypic episodes of frequent seizure activity that are distinct from a patient’s usual seizure pattern in patients with epilepsy 12 years of age and older.

Intec Pharma Ltd. announces that the European Patent Office has granted the Company European Patent No. 2997953 titled, “DELIVERY DEVICE FOR ORAL INTAKE OF AN AGENT,” and covers Intec’s gastro-retentive drug delivery device with perforated external film.